Safe Drug Use in People With Intellectual and/or Developmental Disabilities - it Applies to Life

Disability, Developmental Clinical Trial

Official title: Safe Drug Use in People With Intellectual and/or Developmental Disabilities - it Applies to Life

Status Active, not recruiting

Clinical Trial Summary

The innovation idea is to develop valuable new knowledge about safe drug use in people with intellectual and/or developmental disabilities (IDDs). The main goal is to design a framework (routines and processes) that ensures safe drug use and provides qualitatively better services for people with IDDs. Secondary goals are that employees will experience better security when working with medicines, and interact better with people with IDD and relatives by implementing digital support functions. The innovation idea is specifically to develop/improve the following: 1) Medication management: Coordinating routines, procedures and work processes regarding all aspects of drug use, medication handling, and communication between care units for people with IDDs. 2) Medication therapy: Chart review of prescribed medication and gather knowledge about challenges related to drug use in this group. Based on this, we will develop new methods for drug reconciliation and medication reviews to optimize drug use. 3) New framework for safe drug use in the community-based services for people with IDDs.

Clinical Trial Description

Changing, developing, and testing new routines, procedures, and communication methods for safe drug use is challenging. The complexity of systems that are involved in medication management makes it particularly challenging to create well-designed digital solutions that ensure good working procedures. The complex issues faced by people with IDDs, as well as developments within personalized medicine, means that it is crucial to build new knowledge, work in teams, and arrange for medication reconciliation and medication reviews to be carried out regularly. Furthermore, drug information must be provided, and adapted to the specific individual with an intellectual disability. In addition, the focus on personalized medicine means that the municipality must develop new guidelines for the use of pharmacogenetic tests so that the doctor can tailor drug selection and dosage to the individual patient. ;

Related Conditions & MeSH terms

• Developmental Disabilities
• Disability, Developmental
• Intellectual Disability

• NCT number: NCT06160102
• Study type: Interventional
• Source: Vestvagoy Municipality
• Status: Active, not recruiting
• Phase: N/A
• Start date: August 15, 2023
• Completion date: July 31, 2027